PMDH3: THE USE OF SURROGATE ENDPOINT DATA IN EVALUATING TREATMENT EFFICACY: IMPACT ON DECISION-MAKING AND EXPENDITURE WITHIN THE AUSTRALIAN PHARMACEUTICAL BENEFITS SCHEME
Ruth Lopert
Materials & Design, 2000
View PDFchevron_right
Applying GRADE Criteria to Clinical Inputs to Cost-Effectiveness Modeling Studies
Stephanie Stock
PharmacoEconomics, 2018
View PDFchevron_right
Evidence Synthesis of Treatment Efficacy in Decision Making: A Reviewer's Checklist
Stefanie Reken
National Institute for Health and Care Excellence (NICE), 2012
View PDFchevron_right
International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines
Mike Drummond
Cost effectiveness and resource allocation : C/E, 2017
View PDFchevron_right
How Should the Impact of Different Presentations of Treatment Effects on Patient Choice Be Evaluated? A Pilot Randomized Trial
Shaun Treweek
PLoS …, 2008
View PDFchevron_right
Concordance between decision analysis and matching systematic review of randomized controlled trials in assessment of treatment comparisons: a systematic review
Hesborn Wao
BMC Medical Informatics and Decision Making, 2014
View PDFchevron_right
Advishe: a New Tool to Report Validation of Health-Economic Decision Models
TL Feenstra
Value in Health, 2014
View PDFchevron_right
Statistical methods for cost-effectiveness analyses
noemi kreif
Controlled Clinical Trials, 1996
View PDFchevron_right
PRS47 Use of Propensity Score Matching, Standard Regression Analysis and Instrumental Variable Method in Outcomes Research Studies: A Comparative Analysis
Erdem Baser
Value in Health, 2010
View PDFchevron_right
The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration
Nicholas Forand, Lois Gelfand
PLoS ONE, 2014
View PDFchevron_right
Linking evidence-based medicine therapeutic summary measures to clinical decision analysis
Iztok Hozo
Medgenmed Medscape General Medicine, 2000
View PDFchevron_right
Economic Evaluations Alongside Equivalence and Noninferiority Trials—Reply to Letter to the Editor by Afschin Gandjour
Herman Adèr
Value in Health, 2009
View PDFchevron_right
The Influence of Cost-Effectiveness Evaluations on Reimbursement in Australia: A Retrospective Study of Decisions made by the Pharmaceutical Benefits Advisory Committee
phuong ngo
Pharmaceutical Medicine, 2014
View PDFchevron_right
Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis
Patricia Stone
BMJ, 2004
View PDFchevron_right
A new method for determining physician decision thresholds using empiric, uncertain recommendations
Harold Lehmann
BMC Medical Informatics and Decision Making, 2010
View PDFchevron_right
Cost-effectiveness analysis and formulary decision making in England: Findings from research
J.warren Salmon
Social Science & Medicine, 2007
View PDFchevron_right
Real Medical Benefit Assessed by Indirect Comparison
Myriam Zylberman
Thérapie, 2009
View PDFchevron_right
Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice
A. Edwards, Dorte Jarbøl
BMC Health Services Research, 2013
View PDFchevron_right
Valuing benefits to inform a clinical trial in pharmacy
Anthony Scott
View PDFchevron_right
Development and validation of an instrument designed to measure factors influencing physician prescribing decisions
Mohammad Zayed
Pharmacy Practice
View PDFchevron_right
Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report
John Cook
Value in Health, 2005
View PDFchevron_right
Taking into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference Studies
Ulrik Kihlbom
Patient Preference and Adherence
View PDFchevron_right
Is quality of life a suitable measure of patient decision aid effectiveness? Sub-analysis of a Cochrane systematic review
Orlando Rincones
Quality of Life Research, 2018
View PDFchevron_right
IT'S JUST EVALUATION FOR DECISION-MAKING: RECENT DEVELOPMENTS IN, AND CHALLENGES FOR, COST-EFFECTIVENESS RESEARCH
Ron Akehurst
2000
View PDFchevron_right
Panel 5: Application of Healthcare Intervention Economic Evaluations in Healthcare Decision-Making
Sean Sullivan
Value in Health, 1999
View PDFchevron_right
Bias in published cost effectiveness studies: systematic review
Allison Rosen, Chaim Bell
BMJ, 2006
View PDFchevron_right
Testing the Validity of Cost-Effectiveness Models
Christopher McCabe
View PDFchevron_right